News

Filter

Current filters:

Glatiramer Acetate

1 to 9 of 214 results

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Teva sets goals of $31 billion revenues and non-GAAP net income of $6.8 billion by 2015

08-01-2010

During its investor meeting in New York, USA, yesterday, Israeli generics giant Teva Pharmaceutical Industries…

CopaxoneFinancialGenericsGlatiramer AcetateNorth AmericaPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

New Teva data highlights advances in multiple sclerosis treatment research

09-09-2009

Leading Israeli drugmaker Teva Pharmaceutical Industries says that that new research data furthering…

CopaxoneGlatiramer AcetateImmunologicalsNeurologicalNystatinOralPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

1 to 9 of 214 results

COMPANY SPOTLIGHT

Menarini

Back to top